Cyclopharm (ASX:CYC) Commences Patient Imaging in PRONOSPECT Trial
Cyclopharm (ASX: CYC) has commenced patient imaging for its Technegas in a pivotal French clinical trial aimed at pulmonary embolism diagnosis.
Cyclopharm (ASX: CYC) has commenced patient imaging for its Technegas in a pivotal French clinical trial aimed at pulmonary embolism diagnosis.
Steadfast Group updates on the internal review of its strata insurance practices, reinforcing ethical standards and transparency.
Collins Foods Limited announces its half-year financial results, reporting revenue growth but a decline in profit, and declares an interim dividend.
Regis Healthcare (ASX: REG) has acquired two aged care homes, expanding its national portfolio to 69 homes and 7,750 beds.
Centuria Capital Group reported stable performance and future growth strategies during its 2024 AGM, showcasing resilience amidst economic challenges.
Bio-Gene Technology Limited reports major advancements in its insecticide development and strategic growth plans for 2024.
Peppermint Innovation Limited (ASX:PIL) showcases operational achievements and ambitious future plans at its recent AGM.
Pure Foods Tasmania Ltd (ASX:PFT) announces re-issued financial statements reflecting key updates and improved auditor opinions.
Orcoda Limited (ASX: ODA) shares insights from its AGM presentation, highlighting significant revenue growth and strategic future plans.
Havilah Resources Limited reports substantial progress in its quarterly activity, including successful drilling at Mutooroo and a significant capital raising effort.